Loss of the FAT1 tumor suppressor promotes resistance to CDK4/6 inhibitors via the hippo pathway Z Li, P Razavi, Q Li, W Toy, B Liu, C Ping, W Hsieh, F Sanchez-Vega, ... Cancer cell 34 (6), 893-905. e8, 2018 | 399 | 2018 |
Diverse alterations associated with resistance to KRAS (G12C) inhibition Y Zhao, YR Murciano-Goroff, JY Xue, A Ang, J Lucas, TT Mai, ... Nature 599 (7886), 679-683, 2021 | 289 | 2021 |
Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands I Weinreb, S Piscuoglio, LG Martelotto, D Waggott, CKY Ng, ... Nature genetics 46 (11), 1166-1169, 2014 | 227 | 2014 |
ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer G Xu, S Chhangawala, E Cocco, P Razavi, Y Cai, JE Otto, L Ferrando, ... Nature genetics 52 (2), 198-207, 2020 | 170 | 2020 |
Whole-genome single-cell copy number profiling from formalin-fixed paraffin-embedded samples LG Martelotto, T Baslan, J Kendall, FC Geyer, KA Burke, L Spraggon, ... Nature medicine 23 (3), 376-385, 2017 | 141 | 2017 |
Precision radiotherapy: reduction in radiation for oropharyngeal cancer in the 30 ROC trial N Riaz, E Sherman, X Pei, H Schöder, M Grkovski, R Paudyal, N Katabi, ... JNCI: Journal of the National Cancer Institute 113 (6), 742-751, 2021 | 140 | 2021 |
Ovarian cancer mutational processes drive site-specific immune evasion I Vázquez-García, F Uhlitz, N Ceglia, JLP Lim, M Wu, N Mohibullah, ... Nature 612 (7941), 778-786, 2022 | 135 | 2022 |
Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomas FC Geyer, A Li, AD Papanastasiou, A Smith, P Selenica, KA Burke, ... Nature communications 9 (1), 1816, 2018 | 134 | 2018 |
Loss-of-function mutations in ATP6AP1 and ATP6AP2 in granular cell tumors F Pareja, AH Brandes, T Basili, P Selenica, FC Geyer, D Fan, ... Nature Communications 9 (1), 3533, 2018 | 120 | 2018 |
Analysis of mutational signatures in primary and metastatic endometrial cancer reveals distinct patterns of DNA repair defects and shifts during tumor progression CW Ashley, ADC Paula, R Kumar, D Mandelker, X Pei, N Riaz, ... Gynecologic oncology 152 (1), 11-19, 2019 | 93 | 2019 |
Molecular profiling and molecular classification of endometrioid ovarian carcinomas P Cybulska, ADC Paula, J Tseng, MM Leitao Jr, A Bashashati, ... Gynecologic oncology 154 (3), 516-523, 2019 | 84 | 2019 |
Local iron homeostasis in the breast ductal carcinoma microenvironment O Marques, G Porto, A Rêma, F Faria, A Cruz Paula, M Gomez-Lazaro, ... BMC cancer 16, 1-14, 2016 | 83 | 2016 |
The genomic landscape of mucinous breast cancer F Pareja, JY Lee, DN Brown, S Piscuoglio, R Gularte-Mérida, P Selenica, ... JNCI: Journal of the National Cancer Institute 111 (7), 737-741, 2019 | 82 | 2019 |
Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA SS Chandran, J Ma, MG Klatt, F Dündar, C Bandlamudi, P Razavi, ... Nature medicine 28 (5), 946-957, 2022 | 77 | 2022 |
Mesonephric and mesonephric-like carcinomas of the female genital tract: molecular characterization including cases with mixed histology and matched metastases EM da Silva, DJ Fix, APM Sebastiao, P Selenica, L Ferrando, SH Kim, ... Modern Pathology 34 (8), 1570-1587, 2021 | 74 | 2021 |
Single-cell genomic variation induced by mutational processes in cancer T Funnell, CH O’Flanagan, MJ Williams, A McPherson, S McKinney, ... Nature 612 (7938), 106-115, 2022 | 71 | 2022 |
The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis‐generating study E Guerini‐Rocco, Z Hodi, S Piscuoglio, CKY Ng, EA Rakha, ... The Journal of pathology 237 (2), 166-178, 2015 | 66 | 2015 |
Solid papillary breast carcinomas resembling the tall cell variant of papillary thyroid neoplasms (solid papillary carcinomas with reverse polarity) harbour recurrent mutations … JR Lozada, T Basili, F Pareja, B Alemar, ADC Paula, R Gularte‐Merida, ... Histopathology 73 (2), 339-344, 2018 | 63 | 2018 |
Whole-Exome Sequencing Analysis of the Progression from Non–Low-Grade Ductal Carcinoma In Situ to Invasive Ductal Carcinoma F Pareja, DN Brown, JY Lee, A Da Cruz Paula, P Selenica, R Bi, ... Clinical Cancer Research 26 (14), 3682-3693, 2020 | 61 | 2020 |
Implications of different cancer stem cell phenotypes in breast cancer AC Paula, C Lopes Anticancer research 37 (5), 2173-2183, 2017 | 58 | 2017 |